11C-PiB PET ABri imaging in worster-drought syndrome (Familial British dementia): A case report

Journal of Alzheimer's Disease

Volumn 19, Issue 2, 2010, Pages 423-428

  Villemagne, Victor L ^a,b   Pike, Kerryn ^a,b   Pejoska, Svetlana ^a   Boyd, Alison ^b   Power, Margaret ^b   Jones, Gareth ^a   Masters, Colin L ^b   Rowe, Christopher C ^a  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amyloid; Brain imaging; Familial British Dementia; PiB; Positron emission tomography; Worster Drought syndrome

Indexed keywords

2 (4' METHYLAMINO PHENYL) 6 HYDROXY BENZOTHIAZOLE C 11; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; RADIOPHARMACEUTICAL AGENT; TAU PROTEIN; UNCLASSIFIED DRUG; BENZOTHIAZOLE DERIVATIVE; DIAGNOSTIC AGENT; N METHYL 2 (4' METHYLAMINOPHENYL) 6 HYDROXYBENZOTHIAZOLE; N-METHYL-2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE;

ADULT; ARTICLE; ATAXIA; BETA SHEET; BIOACCUMULATION; BRAIN CORTEX; BRAIN CORTEX ATROPHY; BRAIN REGION; CASE REPORT; CEREBELLUM; CEREBELLUM DISEASE; COGNITION; COGNITIVE DEFECT; COORDINATION DISORDER; DEGENERATIVE DISEASE; DEMENTIA; DISEASE SEVERITY; DRUG DISTRIBUTION; DRUG RETENTION; DYSARTHRIA; DYSDIADOCHOKINESIA; FAMILIAL BRITISH DEMENTIA; GAIT DISORDER; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HETEROZYGOTE DETECTION; HIPPOCAMPUS; HUMAN; HYPERREFLEXIA; MALE; MOTOR COORDINATION; NEOCORTEX; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN FOLDING; METHODOLOGY; MIDDLE AGED; SCINTISCANNING;

BENZOTHIAZOLES; DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY;

EID: 77049107597     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1241     Document Type: Article

References (33)

1. Worster-Drought C, Hill TR, McMenemey WH (1933) Familial presenile dementia with spastic paralysis. J Neurol Psychopathol 14, 27-34.
2. Mead S, James-Galton M, Revesz T, Doshi RB, Harwood G, Pan EL, Ghiso J, Frangione B, Plant G (2000) Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. Brain 123 ( Pt 5), 975-991.
3. Masters CL, Beyreuther K (2001) The Worster-Drought syndrome and other syndromes of dementia with spastic paraparesis: the paradox of molecular pathology. J Neuropathol Exp Neurol 60, 317-319.
4. Vidal R, Frangione B, Rostagno A, Mead S, Revesz T, Plant G, Ghiso J (1999) A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 399, 776-781.
5. Novakovic KE,Villemagne VL, Rowe CC, Masters CL (2005) Rare genetically defined causes of dementia. Int Psychogeriatr 17 Suppl 1, S149-194.
6. Akiyama H, Kondo H, Arai T, Ikeda K, Kato M, Iseki E, Schwab C, McGeer PL (2004) Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol 107, 53-58.
7. Schwab C, Arai T, Hasegawa M, Akiyama H, Yu S, McGeer PL (2009) TDP-43 pathology in familial British dementia. Acta Neuropathol 118, 303-311.
8. Ghiso J, Vidal R, Rostagno A, Mead S, Revesz T, Plant G, Frangione B (2000) A newly formed amyloidogenic fragment due to a stop codon mutation causes familial British dementia. Ann N Y Acad Sci 903, 129-137.
9. Ghiso J, Vidal R, Rostagno A, Miravalle L, Holton JL, Mead S, Revesz T, Plant G, Frangione B (2000) Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13. Ann N Y Acad Sci 920, 84-92.
10. Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, Dekosky ST, Greenberg SM, Hyman BT, Growdon JH (2007) Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol 64, 431-434.
11. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST (2008) Post-mortem correlates of in vivo PiBPET amyloid imaging in a typical case of Alzheimer's disease. Brain 131, 1630-1645.
12. Leinonen V, Alafuzoff I, Aalto S, Suotunen T, Savolainen S, Nagren K, Tapiola T, Pirttila T, Rinne J, Jaaskelainen JE, Soininen H, Rinne JO (2008) Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B. Arch Neurol 65, 1304-1309.
13. Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, Rowe CC (2008) The ART of Loss: Abeta Imaging in the Evaluation of Alzheimer's Disease and other Dementias. Mol Neurobiol 38, 1-15.
14. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
15. Wechsler D,Wechsler test of adult reading. 2001, San Antonio, TX: The Psychological Corporation.
16. Snaith RP, Zigmond AS (1986) The hospital anxiety and depression scale. Br Med J (Clin Res Ed) 292, 344.
17. Saxton J, Ratcliff G, Munro CA, Coffey EC, Becker JT, Fried L, Kuller L (2000) Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clin Neuropsychol 14, 526-534.
18. Wechsler D, WAIS-III administration and scoring manual. 1997, San Antonio, TX: Psychological Corporation.
19. Wechsler D (1945) A standardized memory scale for clinical use. J Psychol 87-95.
20. Delis DC, Kramer JH, Kaplan E, Ober BA, CVLT-II: California Verbal Learning Test, Second Edition, Adult Version. 2000, San Antonio, TX: The Psychological Corporation, a Harcourt Assessment Company.
21. Meyers JE, Bayless JD, Meyers KR (1996) Rey complex figure: memory error patterns and functional abilities. Appl Neuropsychol 3, 89-92.
22. Crook TH, 3rd, Feher EP, Larrabee GJ (1992) Assessment of memory complaint in age-associated memory impairment: the MAC-Q. Int Psychogeriatr 4, 165-176.
23. Strauss E, Sherman EMS, Spreen O, A compendium of Neuropsychological Tests: Administration, Norms and Commentary. Third Edition ed. 2006, New York: Oxford University Press.
24. Benton AL (1968) Differential behavioral effects in frontal lobe disease. Neuropsychologia 6, 53-60.
25. Delis DC, Kaplan EF, Kramer JH, Delis-Kaplan executive function system. 2001, San Antonio: Psychological Corporation.
26. Holton JL, Ghiso J, Lashley T, Rostagno A, Guerin CJ, Gibb G, Houlden H, Ayling H, Martinian L, Anderton BH, Wood NW, Vidal R, Plant G, Frangione B, Revesz T (2001) Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 158, 515-526.
27. Villemagne VL, McLean CA, Reardon K, Boyd A, Lewis V, Klug G, Jones G, Baxendale D, Masters CL, Rowe CC, Collins SJ (2009) 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 80, 998-1001.
28. Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, Hamilton RL, Ikonomovic MD, DeKosky ST, Mathis CA (2003) The binding of 2-(4'- methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 23, 2086-2092.
29. Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortes M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, Villemagne VL (2007) In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J Neurosci 27, 10365-10371.
30. Walker LC, Rosen RF, Levine H, 3rd (2008) Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity? Rom J Morphol Embryol 49, 5-11.
31. Rosen RF, Walker LC, Levine H, 3rd (2009) PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging, in press.
32. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, BiW, Hoge JA, Cohen AD, Ikonomovic MD, Saxton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST (2007) Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27, 6174-6184.
33. Koivunen J, Verkkoniemi A, Aalto S, Paetau A, Ahonen JP, Viitanen M, Nagren K, Rokka J, Haaparanta M, Kalimo H, Rinne JO (2008) PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease. Brain 131, 1845-1853.